Circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)

被引:0
|
作者
Lucci, A.
Hall, C.
Hess, K.
Ravenberg, E.
Clayborn, A.
Mittendorf, E.
Rauch, G.
Candelaria, R.
Moulder, S.
Thompson, A.
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1158/1538-7445.SABCS18-P3-01-01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3-01-01
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Circulating Tumor Cells after Neoadjuvant Therapy in Stage I-III Triple-negative Breast Cancer
    Hall, C.
    Laubacher, B.
    Anderson, A.
    Karhade, M.
    Kuerer, H. M.
    DeSnyder, S.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S17 - S17
  • [22] Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer
    Pierga, J-Y.
    Riva, F.
    Houy, A.
    Saliou, A.
    Madic, J.
    Rampanou, A.
    Hego, C.
    Milder, M.
    Cottu, P.
    Sablin, M-P.
    Vincent-Salomon, A.
    Lantz, O.
    Stern, M-H.
    Proudhon, C.
    Bidard, F-C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)
    Abraham, Jean E.
    Pinilla, Karen
    Grybowicz, Louise
    Dayimu, Alimu
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Hardy, Richard M.
    Chan, Stephen
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, B. Mukesh
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola
    McAdam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    McMurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena
    CANCER RESEARCH, 2024, 84 (07)
  • [24] Effect of adjuvant chemotherapy on the phenotype of circulating tumor cells in patients with triple negative breast cancer
    Kallergi, Galatea
    Dragolia, Melina
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Agelaki, Sofia
    CANCER RESEARCH, 2014, 74 (19)
  • [25] Analysis of Circulating Tumor Cells in Patients with Triple Negative Breast Cancer during Preoperative Chemotherapy
    A. V. Lavrov
    Zh. I. Zubtsova
    D. A. Zubtsov
    M. A. Frolova
    E. O. Ignatova
    M. A. Skrypnikova
    E. V. Malysheva
    E. V. Legchenko
    A. V. Petrovskii
    I. A. Utyashev
    S. A. Tyulyandin
    D. V. Gol’dshtein
    Bulletin of Experimental Biology and Medicine, 2014, 157 : 159 - 161
  • [26] Analysis of Circulating Tumor Cells in Patients with Triple Negative Breast Cancer during Preoperative Chemotherapy
    Lavrov, A. V.
    Zubtsova, Zh I.
    Zubtsov, D. A.
    Frolova, M. A.
    Ignatova, E. O.
    Skrypnikova, M. A.
    Malysheva, E. V.
    Legchenko, E. V.
    Petrovskii, A. V.
    Utyashev, I. A.
    Tyulyandin, S. A.
    Gol'dshtein, D. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 157 (01) : 159 - 161
  • [27] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC)
    Ren, Kuojun
    Wang, Shuhan
    Ye, Tingbo
    Zhu, Zhengzhi
    Hong, Shikai
    Wang, Shengying
    Liu, Jianjun
    BMC CANCER, 2024, 24 (01)
  • [29] Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
    Castaneda, Carlos A.
    Mittendorf, Elizabeth
    Casavilca, Sandro
    Wu, Yun
    Castillo, Miluska
    Arboleda, Patricia
    Nunez, Teresa
    Guerra, Henry
    Barrionuevo, Carlos
    Dolores-Cerna, Ketty
    Belmar-Lopez, Carolina
    Abugattas, Julio
    Calderon, Gabriela
    De La Cruz, Miguel
    Cotrina, Manuel
    Dunstan, Jorge
    Gomez, Henry L.
    Vidaurre, Tatiana
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (05): : 387 - 394
  • [30] Circulating tumor DNA after neoadjuvant chemotherapy is a better prognostic test than Residual Cancer Burden in patients with triple negative breast cancer and residual tumor
    Basik, Mark
    Roseshter, Talia
    Klemantovich, Anna
    Cavallone, Luca
    Aguilar-Mahecha, Adriana
    Lafleur, Josiane
    Lan, Cathy
    Elebute, Oluwadara
    Jenna, Sarah
    Boileau, Jean-Francois
    Pelmus, Manuela
    CANCER RESEARCH, 2024, 84 (09)